Professor T K Lim, Division of Respiratory and Critical Care Medicine, Department of Medicine, National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074; mdclimtk{at}nus.edu.sg ...

Definitions of hypoxaemia, hypoxia, type 1 respiratory failure and hyperoxaemia Definition of hypercapnia and type 2 respiratory failure Definition of acidosis (respiratory acidosis and metabolic ...

Background Critical care medicine has historically relied on syndromic diagnoses such as sepsis, acute respiratory distress ...

Artificial intelligence (AI) is a branch of computer science developed in the 1950s to imitate the human ability for solving ...

4 Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, Australia Correspondence to: Dr D Breen, Intensive Care Unit, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW ...

Background: A limited or absent bronchodilator response is used to classify chronic obstructive pulmonary disease (COPD) and can determine the treatment offered. The reliability of the recommended ...

1 The James Hogg iCAPTURE Center for Cardiovascular and Pulmonary Research, Vancouver, British Columbia, Canada 2 Department of Medicine (Pulmonary Division), University of British Columbia, Vancouver ...

Correspondence to Professor Claire L Shovlin, Professor of Practice (Clinical and Molecular Medicine), NHLI Vascular Science, Imperial College London, Imperial Centre for Translational and ...

Department of Epidemiology and Public Health, University College London, London, UK Dr M Thomas, Department of General Practice and Primary Care, University of Aberdeen, Foresterhill Health Centre, ...

Lung cancer is the commonest fatal malignancy worldwide in both men and women, accounting for >1.3 million deaths each year. The mean time from diagnosis to death is 18 months, new paradigms are ...

Objectives Infliximab, an anti-TNF agent, is used to treat sarcoidosis that does not respond to corticosteroids or second-line agents. The efficacy of other anti-TNF agents, non-TNF biologics and ...

BACKGROUND Patients with severe chronic obstructive pulmonary disease (COPD) have a poor quality of life and limited life expectancy. This study examined whether these patients were relatively ...